Tirzepatide often produces greater weight loss than semaglutide monotherapy in clinical trials and may overcome tolerance in patients who have plateaued
FODMAPs are short-chain carbohydrates that many people, especially those with irritable bowel syndrome (IBS) or sensitive digestive systems, can have difficulty digesting
Energy homeostasis regulation In sports medicine, l-carnitine is used to inhibit glycolysis by suppressing pyruvate dehydrogenase ( Reference Constantin-Teodosiu, Carlin and Cederblad 66 ) , or phosphofructokinase activity ( Reference Eizadi, Bakhshi and Abrifam 67 ) , which reduces exercise-associated lactate accumulation ( Reference Siliprandi, Di Lisa and Pieralisi 68 Reference Vecchiet, Di Lisa and Pieralisi 70 ) , and delays the development of fatigue ( Reference Brass 71 , Reference Karlic and Lohninger 72 )
TRIUMPH-1 is the flagship obesity trial, targeting adults with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as hypertension, dyslipidemia, or obstructive sleep apnea
[10] also found that metformin at doses exhibiting GLP-1-increasing effects exerted no effect on plasma DPP-4 activity in mice
dose adjustment, hydration optimization, and medication alternatives within the GLP-1 class typically resolve headaches while allowing you to continue your weight loss therapy
)
